Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Smallpox01:24

Smallpox

Smallpox is a severe contagious disease caused by the Variola major virus, a double-stranded DNA member of the Poxviridae family.Variola major transmission occurs primarily via inhalation of virus-laden droplets or direct contact with infectious scabs. The incubation period averages approximately seven days, although it may range from 7 to 17 days depending on the inoculum and host factors.Clinically, the prodromal phase is marked by an abrupt onset of high fever, malaise, headache, and myalgia.
Cross-reactivity00:42

Cross-reactivity

Overview
Vaccine Production01:23

Vaccine Production

Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pharmacy-Based Immunization Delivery: A Comprehensive History and Current Challenges.

Journal of the American College of Clinical Pharmacy : JACCP·2026
Same author

Pharmacists' answer to the COVID-19 pandemic: Contribution of the Federal Retail Pharmacy Program to COVID-19 vaccination across sociodemographic characteristics-United States.

Journal of the American Pharmacists Association : JAPhA·2024
Same author

Vaccines against mpox: MVA-BN and LC16m8.

Expert review of vaccines·2024
Same author

Pharmacist assessments and care to improve adult vaccination rates: A report from project IMPACT vaccine confidence.

Journal of the American Pharmacists Association : JAPhA·2024
Same author

Effect of an Innovative Immunization Practice Model to Improve Population Health: Results of the Project IMPACT Immunizations Scaled Demonstration.

Innovations in pharmacy·2023
Same author

Evaluating risk of bias using ROBINS-I tool in nonrandomized studies of adjuvanted influenza vaccine.

Vaccine·2023

Related Experiment Video

Updated: Jun 29, 2026

Safety Precautions and Operating Procedures in an (A)BSL-4 Laboratory: 3. Aerobiology
11:13

Safety Precautions and Operating Procedures in an (A)BSL-4 Laboratory: 3. Aerobiology

Published on: October 3, 2016

Smallpox vaccines for biodefense: need and feasibility.

Andrew W Artenstein1, John D Grabenstein

  • 1Department of Medicine, Brown University, Memorial Hospital of RI, 111 Brewster Street, Pawtucket, RI 02860, USA. artenstein@brown.edu

Expert Review of Vaccines
|October 11, 2008
PubMed
Summary

Smallpox vaccines are being re-evaluated due to bioterrorism concerns. Newer vaccines aim for better safety and efficacy than traditional vaccinia virus vaccines.

More Related Videos

Vaccinia Reporter Viruses for Quantifying Viral Function at All Stages of Gene Expression
10:48

Vaccinia Reporter Viruses for Quantifying Viral Function at All Stages of Gene Expression

Published on: May 15, 2014

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen
07:44

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen

Published on: May 12, 2023

Related Experiment Videos

Last Updated: Jun 29, 2026

Safety Precautions and Operating Procedures in an (A)BSL-4 Laboratory: 3. Aerobiology
11:13

Safety Precautions and Operating Procedures in an (A)BSL-4 Laboratory: 3. Aerobiology

Published on: October 3, 2016

Vaccinia Reporter Viruses for Quantifying Viral Function at All Stages of Gene Expression
10:48

Vaccinia Reporter Viruses for Quantifying Viral Function at All Stages of Gene Expression

Published on: May 15, 2014

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen
07:44

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen

Published on: May 12, 2023

Area of Science:

  • Virology
  • Immunology
  • Public Health

Background:

  • Smallpox, a eradicated infectious disease, is a potential bioterrorism threat.
  • Live vaccinia virus vaccines were historically effective but carry risks.
  • Renewed interest in smallpox countermeasures necessitates vaccine research.

Purpose of the Study:

  • Review the historical use of smallpox vaccines.
  • Assess the current status of next-generation smallpox vaccines.
  • Examine the risk-benefit profile of smallpox vaccination.

Main Methods:

  • Literature review of smallpox vaccine history.
  • Analysis of current research on novel smallpox vaccines.
  • Evaluation of adverse event data and efficacy studies.

Main Results:

  • Live vaccinia virus vaccines have a proven track record but associated adverse events.
  • Newer vaccine candidates show promise for improved safety and sustained efficacy.
  • Ongoing research focuses on balancing protection with reduced side effects.

Conclusions:

  • Smallpox vaccination remains critical for biodefense.
  • Next-generation vaccines offer a potentially safer alternative.
  • Careful risk-benefit assessment is essential for vaccination strategies.